Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign
Widespread vaccination programs have been implemented in many countries to curtail the COVID-19 pandemic, with varying success and challenges. To better understand the successes and challenges of the global COVID-19 response in the face of emerging new variants and epidemiologic data, we discuss how...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-05-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/11/5/953 |
| _version_ | 1797598190308950016 |
|---|---|
| author | Soha Albayat Muna Almaslamani Hamad Alromaihi Hayat Khogali Jesha Mundodan Jean Joury Hammam Haridy |
| author_facet | Soha Albayat Muna Almaslamani Hamad Alromaihi Hayat Khogali Jesha Mundodan Jean Joury Hammam Haridy |
| author_sort | Soha Albayat |
| collection | DOAJ |
| description | Widespread vaccination programs have been implemented in many countries to curtail the COVID-19 pandemic, with varying success and challenges. To better understand the successes and challenges of the global COVID-19 response in the face of emerging new variants and epidemiologic data, we discuss how Qatar engaged the healthcare sector, governmental bodies, and the populace to combat COVID-19, with a focus on the country’s vaccination strategy. This narrative provides the history and timeline of the Qatar COVID-19 vaccination campaign; factors that helped the vaccination campaign and the transferable lessons learned are discussed. Details regarding how Qatar responded to challenges, such as vaccine hesitancy and mitigation of misinformation, are highlighted. Qatar was one of the first countries to procure the BNT162b2 (Comirnaty<sup>®</sup>; Pfizer-BioNTech, Pfizer Inc., New York, NY, USA) and mRNA-1273 (Spikevax<sup>®</sup>; Moderna, Cambridge, MA, USA) COVID-19 vaccines. A relatively high vaccination rate and low case mortality rate (0.14% as of 4 January 2023) was observed in Qatar compared with other countries (global case mortality rate, 1.02%). Learnings will be carried forward as a basis for addressing this evolving pandemic and any future national emergencies in Qatar. |
| first_indexed | 2024-03-11T03:15:52Z |
| format | Article |
| id | doaj.art-de7447efc43a457393725cd4770abd19 |
| institution | Directory Open Access Journal |
| issn | 2076-393X |
| language | English |
| last_indexed | 2024-03-11T03:15:52Z |
| publishDate | 2023-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Vaccines |
| spelling | doaj.art-de7447efc43a457393725cd4770abd192023-11-18T03:36:14ZengMDPI AGVaccines2076-393X2023-05-0111595310.3390/vaccines11050953Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination CampaignSoha Albayat0Muna Almaslamani1Hamad Alromaihi2Hayat Khogali3Jesha Mundodan4Jean Joury5Hammam Haridy6Ministry of Public Health, Doha P.O. Box 42, QatarCommunicable Disease Center, Hamad Medical Corporation, Doha P.O. Box 3050, QatarMinistry of Public Health, Doha P.O. Box 42, QatarMinistry of Public Health, Doha P.O. Box 42, QatarMinistry of Public Health, Doha P.O. Box 42, QatarPfizer Gulf FZ LLC, Dubai P.O. Box 502749, United Arab EmiratesPfizer Gulf FZ LLC, Dubai P.O. Box 502749, United Arab EmiratesWidespread vaccination programs have been implemented in many countries to curtail the COVID-19 pandemic, with varying success and challenges. To better understand the successes and challenges of the global COVID-19 response in the face of emerging new variants and epidemiologic data, we discuss how Qatar engaged the healthcare sector, governmental bodies, and the populace to combat COVID-19, with a focus on the country’s vaccination strategy. This narrative provides the history and timeline of the Qatar COVID-19 vaccination campaign; factors that helped the vaccination campaign and the transferable lessons learned are discussed. Details regarding how Qatar responded to challenges, such as vaccine hesitancy and mitigation of misinformation, are highlighted. Qatar was one of the first countries to procure the BNT162b2 (Comirnaty<sup>®</sup>; Pfizer-BioNTech, Pfizer Inc., New York, NY, USA) and mRNA-1273 (Spikevax<sup>®</sup>; Moderna, Cambridge, MA, USA) COVID-19 vaccines. A relatively high vaccination rate and low case mortality rate (0.14% as of 4 January 2023) was observed in Qatar compared with other countries (global case mortality rate, 1.02%). Learnings will be carried forward as a basis for addressing this evolving pandemic and any future national emergencies in Qatar.https://www.mdpi.com/2076-393X/11/5/953BNT162b2mRNA-1273Qatarvaccination campaignmass vaccination programCOVID-19 vaccines |
| spellingShingle | Soha Albayat Muna Almaslamani Hamad Alromaihi Hayat Khogali Jesha Mundodan Jean Joury Hammam Haridy Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign Vaccines BNT162b2 mRNA-1273 Qatar vaccination campaign mass vaccination program COVID-19 vaccines |
| title | Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign |
| title_full | Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign |
| title_fullStr | Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign |
| title_full_unstemmed | Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign |
| title_short | Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign |
| title_sort | key lessons from covid 19 a narrative review describing qatar s multifactorial approach in executing a vaccination campaign |
| topic | BNT162b2 mRNA-1273 Qatar vaccination campaign mass vaccination program COVID-19 vaccines |
| url | https://www.mdpi.com/2076-393X/11/5/953 |
| work_keys_str_mv | AT sohaalbayat keylessonsfromcovid19anarrativereviewdescribingqatarsmultifactorialapproachinexecutingavaccinationcampaign AT munaalmaslamani keylessonsfromcovid19anarrativereviewdescribingqatarsmultifactorialapproachinexecutingavaccinationcampaign AT hamadalromaihi keylessonsfromcovid19anarrativereviewdescribingqatarsmultifactorialapproachinexecutingavaccinationcampaign AT hayatkhogali keylessonsfromcovid19anarrativereviewdescribingqatarsmultifactorialapproachinexecutingavaccinationcampaign AT jeshamundodan keylessonsfromcovid19anarrativereviewdescribingqatarsmultifactorialapproachinexecutingavaccinationcampaign AT jeanjoury keylessonsfromcovid19anarrativereviewdescribingqatarsmultifactorialapproachinexecutingavaccinationcampaign AT hammamharidy keylessonsfromcovid19anarrativereviewdescribingqatarsmultifactorialapproachinexecutingavaccinationcampaign |